Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KPRX
#4864
Kiora Pharmaceuticals, Inc. Common Stock
2.440
0
USD
+1.67%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.67%
Monthly Change
+15.64%
6 month change
+16.19%
Year Change
+16.19%
Previous Close
2.400
0
Open
2.440
0
Bid
Ask
Low
2.440
0
High
2.440
0
Volume
1
Markets
US Stock Market
Healthcare
KPRX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
19.72 K
35.18 K
213.25 K
2.92 M
3 M
3.95 M
—
Valuation ratios
Enterprise value
—
11.76 M
541.77 K
12.32 M
6.11 M
-913.83 K
18.05 M
Price to earnings ratio
—
-0.85
-0.18
-0.21
3.79
-0.75
-3.85
Price to sales ratio
—
—
-171.23
106.85
0.85
—
—
Price to cash flow ratio
—
-1.28
-0.24
-0.29
1.59
-0.81
-5.07
Price to book ratio
—
1.51
0.22
0.45
0.53
0.5
0.85
Enterprise value to EBITDA ratio
—
-0.67
-0.04
-0.99
1.35
0.07
-1.82
Profitability ratios
Return on assets %
-0.53
-0.91
-0.73
-0.91
0.1
-0.45
-0.4
Return on equity %
-1.16
-1.78
-1.19
-2.05
0.14
-0.67
-0.59
Return on invested capital %
-341.5
-589.26
-473.82
-481.82
131.65
-799.53
-618.8
Gross margin %
100
—
100
100
100
—
—
Operating margin %
-68.1 K
—
84.9 K
-49.35 K
28.15
—
—
EBITDA margin %
-67.83 K
—
84.72 K
-49.05 K
28.27
—
—
Net margin %
-67.1 K
—
93.69 K
-49.07 K
22.44
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.02
5.59
2.35
2.9
4.94
5.99
27.69
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0.64
0
0
Solvency ratios
Debt to assets ratio
0.02
0.03
—
—
—
—
—
Debt to equity ratio
0.05
0.05
—
—
—
—
—
Long term debt to total assets ratio
0.02
0.02
—
—
—
—
—
Long term debt to total equity ratio
0.04
0.03
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-424.17
-128.16
-17.76
2.07
-2.43
-2.42
EBIT per share
—
-660.06
-151.46
-23.35
1.09
-3.13
-3.12
EBITDA per share
—
-658.3
-150.95
-23.25
1.1
-3.12
-3.11
Total debt per share
—
19
—
—
—
—
—
Cash per share
—
306.01
73.3
4.56
6.49
4.16
19.5
Net current asset value per share
—
350.27
94.4
8.81
7.2
5.3
23.13
Tangible book value per share
—
20.6
8.17
-5.03
4.62
3.43
14.94
Working capital per share
—
287.56
54.18
5.77
5.74
4.41
19.61
Book value per share
—
359.38
140.2
11.36
6.24
3.93
20.23
News
Kiora Pharmaceuticals adds retina specialist to advisory board
Kiora Pharmaceuticals receives new patent for KIO-100 formulations
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials
Kiora joins RARE-X Vision Consortium to advance rare eye disease research
Kiora pharma reports Q2 results, advances retinal disease trials
Vicarious Surgical appoints Stephen From as new CEO
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104
Kiora Pharmaceuticals receives patent for ocular disease treatment
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know
kiora pharmaceuticals reports results of annual shareholder meeting
Kiora Pharmaceuticals inks potential $110 million deal with Senju